Treatment Patterns of Patients With Pulmonary Hypertension: A Descriptive Study in Colombia
The Clinical Respiratory Journal · 2025
DOI: 10.1111/crj.70063 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Clinical Respiratory Journal, 2025. Verfasst von Manuel Machado-Duque und 8 weiteren Autor:innen. Beteiligte Einrichtung: Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira y Audifarma S.A, Pereira, Colombia. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Antihypertensive Agents, Practice Patterns, Physicians'. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bayer.
Abstract (Originalsprache)
Introduction
Pulmonary hypertension (PH) is a chronic disease characterized by a progressive rise in pulmonary artery blood pressure. The objective was to describe the treatment patterns among ambulatory patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in a real‐world setting.
Methods
This is a longitudinal cohort follow‐up study characterizing the treatment patterns of patients diagnosed with PAH or CTEPH, with secondary data from a population‐based drug‐dispensing database between 2022 and 2023, which includes sociodemographic, diagnosis, prescribing specialty, and treatment (drugs, persistence of use, and concomitant medications).
Results
In total, 1045 patients with a diagnosis of PH were identified, with mean age of 62.9 ± 18.2 years, and 72.3% of females; of which 947 (90.6%) received monotherapy, and 98 (9.4%) received combination therapy at the beginning of follow‐up. The most frequently used drugs for the treatment of PH were calcium channel blockers (58.1%), followed by phosphodiesterase 5 inhibitors (41.1%), endothelin receptor antagonist (32.5%), and guanylate cyclase stimulants (9.7%). The schemes used most frequently were monotherapy with amlodipine (31.0%), sildenafil (19.2%), or nifedipine (10.0%), but the main combination were sildenafil with nifedipine (2.5%). The mean of persistence of use was 161 ± 123 days during 1 year of follow‐up.
Conclusions
This group of patients with PH from Colombia were treated predominantly with monotherapy of calcium channel blockers and phosphodiesterase 5 inhibitors. However, current clinical practice guidelines recommend the use of combined therapy. The average persistence of the use of drugs for treatment for less than 6 months may be associated with difficulties in follow‐up, adherence, effectiveness, tolerability, and access.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira y Audifarma S.A, Pereira, Colombia.
- Grupo Biomedicina, Fundación Universitaria Autónoma de las Américas, Pereira, Colombia.
- Universidad Tecnológica de Pereira, Pereira, Colombia.
- Medical Affairs, Bayer S.A., Bogotá, Colombia.
ORCID-Profile: Manuel Machado-Duque, Andrés Gaviria-Mendoza, Luis Fernando Valladales-Restrepo, Manuel Pacheco, Jorge E Machado-Alba
Förderung
- Bayer
Zitieren
APA
Machado-Duque, M., Gaviria-Mendoza, A., Valladales-Restrepo, L. F., Pacheco, M., Franco, J. S., Del Rosario Forero, M., Suarez, R., Peñuela, O., & Machado-Alba, J. E. (2025). Treatment Patterns of Patients With Pulmonary Hypertension: A Descriptive Study in Colombia. The Clinical Respiratory Journal. https://doi.org/10.1111/crj.70063
Vancouver
Machado-Duque M, Gaviria-Mendoza A, Valladales-Restrepo LF, Pacheco M, Franco JS, Del Rosario Forero M, et al. Treatment Patterns of Patients With Pulmonary Hypertension: A Descriptive Study in Colombia. The Clinical Respiratory Journal. 2025. doi:10.1111/crj.70063
BibTeX
@article{MachadoDuque2025,
author = {Machado-Duque, Manuel and Gaviria-Mendoza, Andrés and Valladales-Restrepo, Luis Fernando and Pacheco, Manuel and Franco, Juan Sebastián and Del Rosario Forero, María and Suarez, Rubiela and Peñuela, Oscar and Machado-Alba, Jorge E},
title = {Treatment Patterns of Patients With Pulmonary Hypertension: A Descriptive Study in Colombia},
journal = {The Clinical Respiratory Journal},
year = {2025},
doi = {10.1111/crj.70063}
}
EUVIMED